Related Experiment Video
Updated: Jul 16, 2026

A Murine Model of Irreversible and Reversible Unilateral Ureteric Obstruction
Published on: December 20, 2014
Inhibition of MLL1-menin interaction attenuates renal fibrosis in obstructive nephropathy
Jianan Zou1,2, Chao Yu3, Chunyun Zhang1
1Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Abstract:
Mixed lineage leukemia 1 (MLL1), a histone H3 lysine 4 (H3K4) methyltransferase, exerts its enzymatic activity by interacting with menin and other proteins. It is unclear whether inhibition of the MLL1-menin interaction influences epithelial-mesenchymal transition (EMT), renal fibroblast activation, and renal fibrosis. In this study, we investigated the effect of disrupting MLL1-menin interaction on those events and mechanisms involved in a murine model of renal fibrosis induced by unilateral ureteral obstruction (UUO), in cultured mouse proximal tubular cells and renal interstitial fibroblasts. Injury to the kidney increased the expression of MLL1 and menin and H3K4 monomethylation (H3K4me1); MLL1 and menin were expressed in renal epithelial cells and renal interstitial fibroblasts. Inhibition of the MLL1-menin interaction by MI-503 administration or siRNA-mediated silencing of MLL1 attenuated UUO-induced renal fibrosis, and reduced expression of α-smooth muscle actin (α-SMA) and fibronectin. These treatments also inhibited UUO-induced expression of transcription factors Snail and Twist and transforming growth factor β1 (TGF-β1) while expression of E-cadherin was preserved. Moreover, treatment with MI-503 and transfection with either MLL siRNA or menin siRNA inhibited TGF-β1-induced upregulation of α-SMA, fibronectin and Snail, phosphorylation of Smad3 and AKT, and downregulation of E-cadherin in cultured renal epithelial cells. Finally, MI-503 was effective in abrogating serum or TGFβ1-induced transformation of renal interstitial fibroblasts to myofibroblasts in vitro. Taken together, these results suggest that targeting disruption of the MLL1-menin interaction attenuates renal fibrosis through inhibition of partial EMT and renal fibroblast activation.
Insights
Disrupting the Mixed Lineage Leukemia 1 (MLL1)-menin interaction reduces kidney fibrosis by inhibiting partial epithelial-mesenchymal transition (EMT) and renal fibroblast activation.
Area of Science:
- Nephrology
- Molecular Biology
- Epigenetics
Background:
- Mixed Lineage Leukemia 1 (MLL1) is a histone methyltransferase crucial for gene regulation.
- The interaction between MLL1 and menin is essential for MLL1's enzymatic activity.
- The role of MLL1-menin interaction in renal fibrosis, epithelial-mesenchymal transition (EMT), and fibroblast activation remains unclear.
Purpose of the Study:
- To investigate the effect of inhibiting the MLL1-menin interaction on renal fibrosis.
- To explore the impact on epithelial-mesenchymal transition (EMT) and renal fibroblast activation.
- To elucidate the underlying mechanisms in a murine model and cell cultures.
Main Methods:
- Utilized a unilateral ureteral obstruction (UUO) murine model of renal fibrosis.
- Employed MI-503 to inhibit MLL1-menin interaction and siRNA for gene silencing.
- Assessed expression of fibrosis markers (α-SMA, fibronectin), EMT markers (Snail, Twist, E-cadherin), and signaling pathways (Smad3, AKT) in kidney tissues and cultured cells.
Main Results:
- Inhibition of MLL1-menin interaction attenuated UUO-induced renal fibrosis, α-SMA, and fibronectin expression.
- Disruption of MLL1-menin interaction reduced Snail and Twist expression while preserving E-cadherin.
- MI-503 and MLL/menin siRNA inhibited TGF-β1-induced profibrotic changes and myofibroblast transformation in vitro.
Conclusions:
- Targeting the MLL1-menin interaction effectively attenuates renal fibrosis.
- Inhibition of this interaction suppresses partial EMT and renal fibroblast activation.
- Disrupting the MLL1-menin complex represents a potential therapeutic strategy for kidney fibrosis.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

